CME/CE

Use the tool below to view all available AXISMedEd Activities

Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits
- Benjamin Levy, MD
0.25 credits
Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach
Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach
CME/CE
Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach
0.25 credits
- Heather Wakelee, MD, FASCO
0.25 credits
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
CME/CE
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
0.25 credits
- Reshma L. Mahtani, DO
0.25 credits
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
CME/CE
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
0.50 credits
- Natasha B. Leighl, MD, MMSc
0.50 credits
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
CME/CE
From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
1.50 credits
- Theresa W. Gillespie, PhD, MA, RN, FAAN
- Kristi Orbaugh, MSN, RNP, AOCN
- Kimberly Podsada, MSN, NP-C
1.50 credits
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CE
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
0.50 credits
- Carlos M. de Castro, MD
0.50 credits

CME/CE

Popular

Title